Gene · 92521
NIH grants1,071
NIH grants whose papers are about the gene, through NIH's grant-paper links.
581 to 600 of 1,071
Download this page as JSON| Grant | Title | SPECC1 papers | Newest fiscal year |
|---|---|---|---|
| R33CA225498 | Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers | 2 | 2021 |
| R56AG074001 | Multimodal single-cell genomic and epigenomic analyses elucidate Alzheimer’s sexual dimorphism in human immune systems aging | 2 | 2021 |
| S10OD030330 | Tandem Multi-modal Plate Readers for a High Throughput Screening platform | 2 | 2021 |
| T32GM064337 | Research Training in Chemistry and Chemical Biology | 2 | 2021 |
| U19AI100625 | Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross | 2 | 2021 |
| U24TR002306 | CD2H - National COVID Cohort Collaborative (N3C) | 2 | 2021 |
| U54AI150472 | HIV Interactions In Viral Evolution | 2 | 2021 |
| U54CA209891 | Research Center for Cancer Systems Biology: Cancer Cell Map Initiative | 2 | 2021 |
| U54CA209992 | Analysis of the regulatory networks regulating district stem cell-like states in aggressive cancers | 2 | 2021 |
| UM1AI126620 | First-in-human study of two anti-SARS CoV-2 antibodies in health volunteers | 2 | 2021 |
| F30AA026497 | The Role and Mechanisms of Clic4 in Modifying Ethanol-Related Behaviors | 1 | 2021 |
| F30CA239476 | Investigating functional interactions with KRAS G12C inhibition | 1 | 2021 |
| F31GM131635 | Fragment-based drug design and substrate envelope model of the Zika virus protease | 1 | 2021 |
| F31HG010820 | Interrogating Enhancer Function and Cooperation by Systematic Perturbation of Transposable Elements | 1 | 2021 |
| F32GM133144 | Heterogenous cytoplasmic RNA-protein aggregates enhance cellular survival under stress | 1 | 2021 |
| I01BX004235 | Targeting Macrophage Lysosome Biogenesis Program in Cardiomyopathy and Heart Failure | 1 | 2021 |
| K00CA223018 | A biophysical approach to elucidating the molecular mechanisms of mitotic inhibitor targets | 1 | 2021 |
| K08HL135434 | Targeting SETBP1 in Myeloproliferative Disorders | 1 | 2021 |
| K23AI129659 | Determining the component causes of systemic immune activation that moderate HIV acquisition and establishment of the latent viral reservoir | 1 | 2021 |
| K99DE028573 | Molecular regulatory mechanism of Zika virus-induced intracranial calcifications | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/grants?page=30